12/01/2026
๐๐ซ๐๐๐ค๐ข๐ง๐ : ๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐ซ๐๐๐ค๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก โจ
Excited to share a major breakthrough from the ๐จ๐ป๐ถ๐๐ฒ๐ฟ๐๐ถ๐๐ ๐ผ๐ณ ๐๐ฟ๐ถ๐๐ถ๐๐ต ๐๐ผ๐น๐๐บ๐ฏ๐ถ๐ฎ, where researchers have, for the first time, demonstrated a reliable method to produce ๐ต๐ฒ๐น๐ฝ๐ฒ๐ฟ-๐ง ๐ถ๐บ๐บ๐๐ป๐ฒ ๐ฐ๐ฒ๐น๐น๐ from stem cells in the controlled laboratory setting.
By adjusting key biological signals, the team can now precisely direct stem cells to develop into either helper or killer T cells.
The study marks a significant step toward ๐ถ๐บ๐บ๐๐ป๐ผ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐, addressing one of the major challenges in scalability and paving the way for more accessible, effective, off-the-shelf treatments across cancer, infectious diseases, autoimmune disorders and more.
๐ฅ๐ฒ๐ฎ๐ฑ ๐บ๐ผ๐ฟ๐ฒ ๐
UBC researchers discover how to grow specialized immune cells for more accessible off-the-shelf cell therapies to treat cancer, autoimmune disorders and more.